A review paper dropped in April 2026 that’s been making the rounds on Instagram, racking up thousands of likes and getting shared with captions like “the science is settled” and “seed oils are safe—stop falling for social media fear-mongering.”

The paper, published in Critical Reviews in Food Science and Nutrition, is titled “Concerns about the health effects of industrially produced seed oils are without scientific foundation.” That’s not a cautious conclusion from researchers following the data—that’s a declaration. And if you’ve spent any time in this space, a title that definitive from a nutrition review probably warrants a closer look at who funded it, who wrote it, and what questions it chose not to ask.

I took that closer look. What I found didn’t surprise me—it just disappointed me, because I’ve seen this pattern play out enough times that the moves are becoming predictable.

Follow the Money

The review was partially funded by the Soy Nutrition Institute Global, with support from the United Soybean Board. The corresponding author, Mark Messina, is the Director of Nutrition Science and Research for the Soy Nutrition Institute Global. He’s spent the last 30 years studying and promoting the health effects of soy products. That’s his career. That’s his employer. That’s his income.

I want to be fair here—having a funding source doesn’t automatically invalidate research. Researchers need funding, and industry involvement in nutrition science is common. I get that. The issue isn’t that industry money exists; the issue is what happens to the conclusions when industry money is present.

There’s a well-documented pattern. A 2013 analysis found that studies funded by Coca-Cola, PepsiCo, and the sugar industry were five times more likely to find no link between sugary drinks and weight gain compared to studies without those financial ties. Five times. That’s not a subtle tilt—that’s a consistent, measurable skew toward conclusions that protect the funder’s product.

The soy and seed oil industry isn’t doing anything new here. The United Soybean Board’s own press materials openly describe their strategy: promoting soybean oil to increase sales, funding research to support favorable conclusions, and investing in communications to shape public perception. They’ve stated publicly that “case studies confirm promoting vegetable oil as 100% soybean will increase sales.” That’s not a secret—it’s a press release.

When the organization funding the research has a stated financial goal of increasing sales of the product being studied, and the lead author is an employee of that organization, we’re not looking at independent science. We’re looking at a marketing document dressed in a lab coat.

The Study Design Problem

This is where the distinction between study types matters—something I’ve written about before and something I genuinely believe every person interested in their own health deserves to understand.

The Nagra et al. paper is a “scoping narrative review.” That sounds impressive until you understand what it means methodologically. A scoping narrative review is not a systematic review. It’s not a meta-analysis. There’s no pre-registered protocol dictating which studies get included or excluded. The authors choose what to include, what to leave out, and how to frame it.

In a systematic review, the methodology protects against cherry-picking. The inclusion criteria are set before the search begins, and every study meeting those criteria gets included—whether the results are favorable or not. In a scoping narrative review, that protection doesn’t exist. The authors have the latitude to select studies that support their thesis and exclude studies that don’t—and there’s no structural mechanism to prevent that from happening.

This is a problem on its own. It becomes a much bigger problem when the people choosing which studies to include are financially tied to the industry whose product is being evaluated.

What the Review Actually Examined—and What It Didn’t

Here’s where the real gap lives, and it’s the part I wish more people would sit with.

The review largely focuses on whether isolated linoleic acid—the primary omega-6 fatty acid in seed oils—raises inflammation markers in controlled clinical trials. Their conclusion: LA doesn’t appear to be pro-inflammatory in these studies.

On the surface, that sounds reassuring. The problem is that it’s answering a conveniently narrow question while ignoring the clinically relevant one.

The question isn’t whether swallowing a linoleic acid capsule in a controlled trial raises a handful of inflammation markers over a few weeks. The question—the one that matters for real people eating real food in real kitchens—is what happens when linoleic acid is consumed in the form of repeatedly heated seed oils, and what happens to its oxidized metabolites inside the body over time.

Those metabolites are called OXLAMs—oxidized linoleic acid metabolites. And the research on them tells a very different story than the one this review is selling.

The OXLAM Literature They Walked Past

Christopher Ramsden’s work at the NIH has been quietly building one of the most important bodies of evidence in this space, and it’s conspicuously absent from this conversation.

In 2012, Ramsden and colleagues showed that lowering dietary linoleic acid reduced plasma OXLAMs significantly. These aren’t abstract metabolites with unclear significance—the same paper explicitly states that OXLAMs have been mechanistically linked to cardiovascular disease, chronic pain, Alzheimer’s dementia, and non-alcoholic steatohepatitis (NASH). Those are four of the most prevalent chronic conditions driving suffering and death in modern populations.

In 2018, Ramsden’s team demonstrated that increasing dietary LA increased omega-6 fatty acids and OXLAMs in brain tissue while simultaneously decreasing omega-3 fatty acids. The dietary ratio isn’t just a blood marker conversation—it’s changing the composition of the brain itself.

A related line of research from Warner, Ramsden, and Schuster showed that specific OXLAMs—particularly 9-HODE—induced proinflammatory cytokine expression in macrophages. This is a concrete, mechanistic pathway from linoleic acid consumption to inflammatory signaling in immune cells. It’s not theoretical; it’s demonstrated.

The Nagra review sidesteps this entire body of work by asking a narrower question: does isolated LA in a capsule raise CRP in a controlled trial? That’s like testing whether holding a single match is dangerous while ignoring the warehouse full of gasoline behind you.

The Heated Oil Gap

This might be the most important distinction the review fails to address, and it’s the one that matters most for the people I work with—private clients and clinic patients who are cooking with these oils every day.

When seed oils rich in linoleic acid are heated to frying temperatures, they produce a compound called 4-hydroxynonenal, or 4-HNE. This isn’t a fringe claim; 4-HNE is a well-characterized reactive aldehyde that’s cytotoxic and mutagenic. It’s formed when polyunsaturated fats break down under heat, and soybean oil—the oil most consumed in the United States and the one most directly supported by this review’s funders—is particularly prone to producing it.

The distance between “LA capsule in a controlled trial” and “repeatedly heated soybean oil in a fast-food fryer or home kitchen” is enormous. The review doesn’t address that distance. It doesn’t acknowledge that the form in which most people actually consume linoleic acid—in heated, oxidized, reheated cooking oils—bears almost no resemblance to the isolated LA used in the clinical trials it cites.

This is where I get frustrated, because the people reading this review and walking away feeling reassured aren’t consuming pristine LA capsules. They’re eating french fries cooked in soybean oil that’s been heated, cooled, and reheated for days. They’re consuming packaged foods made with oils that were already oxidized before they ever left the factory. The clinical picture is not the same—and treating it as though it is does a disservice to every person trying to make an informed decision about what they eat.

The Playbook Isn’t New

I want to step back and say something I think matters, even though it could be taken the wrong way.

I don’t think the researchers who worked on this review are bad people. I don’t think they sat down and said, “Let’s deceive the public.” I believe—genuinely—that most people in nutrition science got into this field because they wanted to help people eat better and live healthier.

What concerns me isn’t the intent; it’s the structure. When an industry with a financial stake in a product’s reputation funds the research evaluating that product, and the corresponding author is an employee of that industry, and the study design allows the authors to choose which evidence to include—the structural incentives push toward favorable conclusions whether anyone consciously intends it or not.

We’ve seen this before. We saw it with tobacco. We saw it with sugar. We saw it with soda. In every case, industry-funded research consistently reached conclusions favorable to the funder’s product, and in every case, it took decades for the independent science to cut through the noise and reach the public.

I’ve written before about how to read nutrition research critically, and the principles I outlined there apply here in full force: Who funded it? What type of study is it? What question is it actually asking—and what questions is it not asking? Those three questions would save a lot of people from being misled by headlines that declare the debate is over.

Why This Matters for Our Audience

Here’s what I want you to sit with.

The people I serve—both in my private practice and at the metabolic health clinic—are not controlled trial participants. They’re metabolically dysregulated humans eating in the real world. They’re dealing with insulin resistance, chronic inflammation, autoimmune conditions, and years of dietary habits built on food products made with these exact oils.

When I see someone’s inflammatory markers come down after they remove seed oils from their diet—when their joint pain improves, when their skin clears, when their digestion normalizes—I don’t need a scoping narrative review funded by the soybean industry to tell me whether what I’m seeing is real. The clinical picture is clear, and it repeats itself with enough consistency that I feel comfortable sharing it.

That doesn’t mean the science is settled—I’d never say that about anything in nutrition. What I see clinically, so far, is consistent enough that it’s worth paying attention to. The research on OXLAMs, on heated-oil degradation products, and on the mechanistic pathways from linoleic acid to inflammation all point in the same direction as what I observe in practice. When a review asks a conveniently narrow question and declares victory while ignoring the broader evidence, it’s not settling the science—it’s curating it.

Your body is the experiment that matters most. If you’ve felt better after reducing or eliminating seed oils, I don’t think a marketing-funded review paper gives you any reason to doubt that experience. Pay attention to the funding. Pay attention to the study design. Pay attention to the questions that aren’t being asked.

I hope this connects some dots—and I hope it empowers you to keep asking the uncomfortable questions. The people funding these reviews would rather you didn’t.

Sources

  • Ramsden CE, et al. “Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73).” BMJ, 2016. 10.1136/bmj.i1246
  • Ramsden CE, et al. “Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis.” BMJ, 2013. 10.1136/bmj.e8707

Rance Edwards is a National Board Certified Health and Wellness Coach (NBC-HWC) with over 2,000 clinical hours of experience, specializing in chronic disease management and lifestyle medicine.

If you’re sorting through conflicting nutrition information and want someone in your corner who actually looks at the research—not just the headlines—I’d love to talk. Book a free discovery call—no pressure, just a conversation about where you are and what might help.

Hero photo by Edward Jenner on Pexels.